CME Group Stock-Based Compensation — Historical Data
CME Group (CME) stock-based compensation was $96M in FY2025 (+6% YoY). The tables below show the complete quarterly and annual stock-based compensation history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Stock-Based Compensation
Fiscal Year
Stock-Based Compensation
YoY
2025
$96M
+6%
2024
$90M
+8%
2023
$84M
-1%
2022
$85M
+11%
2021
$76M
-21%
2020
$97M
+13%
2019
$86M
-11%
2018
$97M
+66%
2017
$58M
-12%
2016
$66M
+9%
2015
$61M
+11%
2014
$55M
+1%
2013
$54M
-11%
2012
$61M
+20%
2011
$51M
+25%
2010
$41M
+22%
2009
$33M
-11%
2008
$38M
+64%
2007
$23M
Recent Quarterly Stock-Based Compensation
Quarter
Stock-Based Compensation
Q2 2026
$25M
Q1 2026
$22M
Q4 2025
$30M
Q3 2025
$24M
Q2 2025
$21M
Q1 2025
$21M
Q4 2024
$28M
Q3 2024
$20M
Q2 2024
$19M
Q1 2024
$23M
Q4 2023
$25M
Q3 2023
$19M
Source: CME on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.